National registry of human embryonic stem cell lines

This registry lists human pluripotent stem cell lines derived directly from embryos, in a manner consistent with TCPS 2 or, prior to December 18, 2014 to the Guidelines for Human Pluripotent Stem Cell Research. Induced human pluripotent stem cell lines will not be listed with the registry, as they are not derived from embryonic sources.

All human embryonic stem cell lines derived under the auspices of an Institution eligible for Agency funding must be listed in the registry. However, prior to June 30, 2010, only human embryonic stem cell lines derived in the course of CIHR-funded projects were required to be listed in the registry.

To date, no human embryonic stem cell lines have been derived in the course of CIHR-funded projects. Investigators with lines derived prior to June 30, 2010 under the auspices of an eligible institution voluntarily listed their cell lines.

Lines listed here will be made available by the researcher to other researchers, subject to reasonable cost-recovery charges. Note that research conducted under the auspices of an eligible institution using these cell lines must be reviewed and approved by its Research Ethics Board (REB) and the Stem Cell Oversight Committee (SCOC) before the work can commence.

A list of human embryonic stem cell lines that have been reviewed by SCOC, found to conform to TCPS 2 or, prior to December 2014, the Guidelines, and approved by CIHR's Governing Council is available in the Frequently Asked Questions. Note that research conducted under the auspices of an eligible institution using these cell lines must also be reviewed and approved by its REB and SCOC before the work can commence.

To date, no decision has been made to disallow a human embryonic stem cell line submitted for SCOC review. When applicable, lines that have been disallowed will be listed here.

Date modified:

2023-02-07